uniQure N.V. (NASDAQ: QURE)
$6.0100
+0.2300 ( +2.39% ) 233.7K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$6.0100
Previous close
$5.7800
Volume
233.7K
Market cap
$301.72M
Day range
$5.7800 - $6.2350
52 week range
$3.7300 - $11.3500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 17, 2024 |
8-k | 8K-related | 15 | Jun 03, 2024 |
10-q | Quarterly Reports | 62 | May 07, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |
ars | Annual reports | 1 | May 01, 2024 |
def | Proxies and info statements | 20 | Apr 24, 2024 |
pre | Proxies and info statements | 21 | Apr 12, 2024 |
8-k | 8K-related | 13 | Apr 12, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |